A federal district court judge yesterday ruled that the Department of Health and Human Services would get "first crack at crafting appropriate remedial measures" to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program. He also held that, like the 2018 cuts, the 2019 cuts to 340B hospitals were unlawful. The judge said that he expected HHS to “act expeditiously to resolve these issues” and required HHS to report back to him on or before Aug. 5 with its remedy proposal.
 
In a statement, the AHA, Association of American Medical Colleges and America’s Essential Hospitals said, “America’s 340B hospitals are pleased with the District Court’s decision and urge HHS to follow the judge’s directive to promptly resolve the harm caused by its unlawful cuts to Medicare reimbursement for certain 340B hospitals.” The groups also urged HHS to “promptly comply with the judge’s ruling and restore to 340B hospitals all funds that have been unlawfully withheld.” 

A federal judge Dec. 27 ruled in favor of the AHA and hospital plaintiffs that HHS's nearly 30 percent cut of 2018 Medicare payment rates for many hospitals in the 340B program was unlawful. The lawsuit was brought by the AHA, AAMC, AEH and three hospital plaintiffs.

Related News Articles

Headline
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug…
Headline
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at…
Headline
Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its proposed 340B rebate model.…
Headline
The Centers for Medicare & Medicaid Services Sept. 27 announced that average premiums, benefits and plan choices for Medicare Advantage and Part D will…
Headline
The Department of Health and Human Services’ Office of Inspector General Sept. 24 recommended that additional oversight is needed to ensure that remote patient…
Headline
The Health Resources and Services Administration Sept. 27 sent a final warning letter to Johnson & Johnson urging the company to inform the agency by…